Accelerant Holdings NYSE: ARX jumped into view for investors in mid-August after its shares surged 43% in a single day. This type of share price leap is often reserved for clinical-stage biotech firms

MILWAUKEE, Aug. 13, 2026 /PRNewswire/ -- Ademi LLP is investigating Accelerant (NYSE: ARX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction wit